tiprankstipranks
Trending News
More News >
SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market

SAB Biotherapeutics (SABS) Revenue

Compare
139 Followers

SAB Biotherapeutics Revenue

SAB Biotherapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2025, with -100.00%. This bring the company's revenue in the last twelve months to 377.83K, Increased -71.43%. In the fiscal year ending Dec 31, 2024, SAB Biotherapeutics had annual revenue of 1.32M with -40.96% growth.
Revenue (ttm)
377.83K
Revenue Growth
-85.48%
P/S Ratio
12.58
Revenue/Employee
$20,984
Employees
63
Market Cap
$16.63M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
1.32M-917.00K-40.96%
Dec 31, 2023
2.24M-21.66M-90.63%
Dec 31, 2022
23.90M-36.97M-60.73%
Dec 31, 2021
60.88M5.64M+10.21%
Dec 31, 2020
55.24M51.80M+1,504.82%
Dec 31, 2019
3.44M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis